Spatial data aggregation for spatio-temporal individual-level models of infectious disease transmission

A discrete-time susceptible-infectious-recovered-susceptible model for the analysis of influenza data

We develop a discrete time compartmental model to describe the spread of seasonal influenza virus. As time and disease state variables are assumed to be discrete, this model is considered to be a discrete time, stochastic, Susceptible-Infectious-Recovered-Susceptible (DT-SIRS) model, where weekly counts of disease are assumed to follow a Poisson distribution. We allow the disease transmission rate to also vary over time, and the disease can only be reintroduced after extinction if there is a contact with infected individuals from other host populations. To capture the variability of influenza activities from one season to the next, we define the seasonality with a 4-week period effect that may change over years. We examine three different transmission rates and compare their performance to that of existing approaches. Even though there is limited information for susceptible and recovered individuals, we demonstrate that the simple models for transmission rates effectively capture the behaviour of the disease dynamics. We use a Bayesian approach for inference. The framework is applied in an analysis of the temporal spread of influenza in the province of Manitoba, Canada, 2012-2015.

Spatial aggregation choice in the era of digital and administrative surveillance data

Traditional disease surveillance is increasingly being complemented by data from non-traditional sources like medical claims, electronic health records, and participatory syndromic data platforms. As non-traditional data are often collected at the individual-level and are convenience samples from a population, choices must be made on the aggregation of these data for epidemiological inference. Our study seeks to understand the influence of spatial aggregation choice on our understanding of disease spread with a case study of influenza-like illness in the United States. Using U.S. medical claims data from 2002 to 2009, we examined the epidemic source location, onset and peak season timing, and epidemic duration of influenza seasons for data aggregated to the county and state scales. We also compared spatial autocorrelation and tested the relative magnitude of spatial aggregation differences between onset and peak measures of disease burden. We found discrepancies in the inferred epidemic source locations and estimated influenza season onsets and peaks when comparing county and state-level data. Spatial autocorrelation was detected across more expansive geographic ranges during the peak season as compared to the early flu season, and there were greater spatial aggregation differences in early season measures as well. Epidemiological inferences are more sensitive to spatial scale early on during U.S. influenza seasons, when there is greater heterogeneity in timing, intensity, and geographic spread of the epidemics. Users of non-traditional disease surveillance should carefully consider how to extract accurate disease signals from finer-scaled data for early use in disease outbreaks.

Mind the Scales: Harnessing Spatial Big Data for Infectious Disease Surveillance and Inference

Spatial big data have the velocity, volume, and variety of big data sources and contain additional geographic information. Digital data sources, such as medical claims, mobile phone call data records, and geographically tagged tweets, have entered infectious diseases epidemiology as novel sources of data to complement traditional infectious disease surveillance. In this work, we provide examples of how spatial big data have been used thus far in epidemiological analyses and describe opportunities for these sources to improve disease-mitigation strategies and public health coordination. In addition, we consider the technical, practical, and ethical challenges with the use of spatial big data in infectious disease surveillance and inference. Finally, we discuss the implications of the rising use of spatial big data in epidemiology to health risk communication, and public health policy recommendations and coordination across scales.